CARDIOVASCULAR DISEASE IN WOMEN: Expert Panel Statement of Women in Cardiology of Hellenic Cardiological Society. Main Text

  • List of Authors CHRISTINA CHRYSOHOOU, CONSTANTINA AGGELI, KATERINA AVGEROPOULOU, MARIA ARONI MARIA BONOU, MARIA BOUTSIKOU STELLA BRILI, EFTYHIA CHAMODRAKA, ANNA DAGRE, PANAGIOTA FLEVARI, AIKATERINI FOUNTOULAKI, ALEXANDRA FROGOUDAKI, JULIA GRAPSA, AGGELIKI GKOUZIOUTA, ELENI HATZINIKOLAOU-KOTSAKOU, KALLIROI KALANTZI, ANASTASIA KITSIOU, PANAGIOTA KOSTAKOU, ROY KOUREA, PARASKEVI KOUTROLOU-SOTIROPOULOU, MARIA MARKETOU, SOPHIE MAVROGENI, KATERINA K NAKA, MARIA NIKOLAOU, OURANIA PAPAZACHOU, LIDA PIERETTA PAPAVASILEIOU, EFTIHIA SIMEONIDOU, ARTEMISIA THEOPISTOU, HELEN TRIANTAFYLLIDI CHRYSANTHI TRIKKA, DOROTHEA TSEKOURA, APHRODITE TZIFA, SOPHIA VAINA, AGATHI ROSA VRETTOU, THEODORA, ZAGLAVARA,GENOVEFA KOLOVOU.

Περίληψη

The perception that women represent a low risk population for cardiovascular disease (CVD) needs to be reconsidered. Starting from risk factors, women are more likely to be susceptible to unhealthy behaviors and risk factors that have different impact on CV morbidity and mortality compared to men. Despite the large body of evidence as regards the effect of lifestyle factors on the CVD onset, the gender-specific effect of traditional and non-traditional risk factors on the prognosis of patients with already established CVD has not been well investigated and understood. Furthermore, CVD in women is often misdiagnosed, underestimated and undertreated. Women also experience hormonal changes from adolescence till elder life that affect CV physiology. Unfortunately, in most of the clinical trials women are under-represented, leading to limited knowledge of CV and systemic impact effects of several treatment modalities on women’s health. Thus, in this manuscript a group of female Cardiologists from the Hellenic Society of Cardiology present the special features of CVD in women: the different needs in primary and secondary prevention, as well as therapeutic strategies, that may be implemented in daily clinical practice in order to eliminate underestimation and undertreatment of CVD in female population.

Δημοσιευμένα
2021-02-25
How to Cite
AUTHORS, List of. CARDIOVASCULAR DISEASE IN WOMEN: Expert Panel Statement of Women in Cardiology of Hellenic Cardiological Society. Main Text. hellenicjcardiol, [S.l.], v. 61, n. 6, p. 1-57, feb. 2021. Available at: <http://hellenicjcardiol-gr.gr/index.php/hjc/article/view/365>. Date accessed: 20 june 2021.
Ενότητα
ΚΑΤΕΥΘΥΝΤΗΡΙΕΣ ΟΔΗΓΙΕΣ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ